Serotonin syndrome in a Parkinson disease patient after intake of an ethanol-containing homeopathic medication

被引:2
作者
Suratos, Cezar Thomas R. [1 ]
Del Rosario, Mark M. [2 ]
Jamora, Roland Dominic G. [1 ,3 ,4 ]
机构
[1] Univ Philippines Manila, Coll Med, Dept Neurosci, Philippine Gen Hosp, Manila, Philippines
[2] St Lukes Med Ctr, Sect Neurol, Inst Neurosci, Quezon City, Philippines
[3] St Lukes Med Ctr, Movement Disorders Serv, Inst Neurosci, Quezon City, Philippines
[4] St Lukes Med Ctr, Movement Disorders Serv, Inst Neurosci, Global City, Philippines
关键词
drug interaction; homeopathic medicine; Parkinson disease; serotonin syndrome; ANTIDEPRESSANT;
D O I
10.2217/nmt-2020-0006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Serotonin syndrome is due to excess serotonin in the nervous system. We document a case of an elderly Parkinson disease patient who has been neurologically stable on rasagiline and escitalopram for 1 year but developed serotonin syndrome after intake of an ethanol-containing homeopathic medication. The patient presented with seizures, autonomic dysfunction and neuromuscular hyperexcitability. Maintenance medications were discontinued, hydration, sedation and respiratory support were provided with resolution of the symptoms. The combination of escitalopram and ethanol, both metabolized by the cytochrome P450 enzyme system can lead to serotonin syndrome. Our case highlights the importance of drug interactions in patients taking several medications. Additionally, the intake of medicines, may it be conventional or homeopathic medicine, without the guidance of a trained and competent physician, may lead to serious consequences for the patient.
引用
收藏
页码:219 / 222
页数:4
相关论文
共 12 条
[1]   A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system [J].
Bell, Iris R. ;
Koithan, Mary .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 12
[2]   Global Ethanol-Induced Enhancements of Monoaminergic Neurotransmission: A Meta-Analysis Study [J].
Brand, Ines ;
Fliegel, Sarah ;
Spanagel, Rainer ;
Noori, Hamid R. .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 (12) :2048-2057
[3]   Low Potency Homeopathic Remedies and Allopathic Herbal Medicines: Is There an Overlap? [J].
Csupor, Dezso ;
Boros, Klara ;
Hohmann, Judit .
PLOS ONE, 2013, 8 (09)
[4]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[5]   The Bell Tolls for Homeopathy: Time for Change in the Training and Practice of North American Naturopathic Physicians [J].
Nelson, David H. ;
Perchaluk, Jaclyn M. ;
Logan, Alan C. ;
Katzman, Martin A. .
JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE, 2019, 24
[6]   Adverse effects of homeopathy: a systematic review of published case reports and case series [J].
Posadzki, P. ;
Alotaibi, A. ;
Ernst, E. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (12) :1178-1188
[7]   The clinical pharmacokinetics of escitalopram [J].
Rao, Niranjan .
CLINICAL PHARMACOKINETICS, 2007, 46 (04) :281-290
[8]   Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease [J].
Richard, IH ;
Kurlan, R ;
Tanner, C ;
Factor, S ;
Hubble, J ;
Suchowersky, O ;
Waters, C ;
Goetz, C ;
Juncos, JL ;
Stern, M ;
Harrison, MB ;
Sethi, KD ;
Standaert, D ;
Trosch, R ;
Reich, S ;
Kieburtz, K ;
Feigin, A ;
Marshall, FJ ;
Gauthier, S ;
Panisset, M ;
Lew, ME ;
Friedman, JH ;
Paulson, G ;
Rodnitzky, RL ;
Hauser, R ;
Kurth, M ;
Hurtig, H ;
Thal, L ;
Elmer, LW ;
Perlmutter, JS ;
Golbe, LI ;
Comella, C ;
Lang, A ;
Mark, MH ;
Singer, C ;
Shoulson, I ;
Weiner, WJ ;
Pfeiffer, R ;
Marek, KL ;
Nutt, J ;
Wooten, GF ;
Jankovic, J ;
LeWitt, P ;
Hoehn, M ;
Bennett, J ;
Parsa, M ;
Koller, W .
NEUROLOGY, 1997, 48 (04) :1070-1077
[9]   Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study Effects on Nonmotor Symptoms and Tolerability [J].
Smith, Kara M. ;
Eyal, Eli ;
Weintraub, Daniel .
JAMA NEUROLOGY, 2015, 72 (01) :88-95
[10]  
Suzuki Akihito, 2019, Clin Neuropharmacol, V42, P103, DOI 10.1097/WNF.0000000000000331